Cosmo and Medtronic unveil the future of AI in GI:
Genius Summit 2024 reveals innovations and collaborations that advance endoscopic care
Cosmo Pharmaceuticals N.V. (“Cosmo”) announces that Medtronic plc (NYSE: MDT), a global leader in healthcare technology, presented at the Genius Summit 2024 the latest advancements in artificial intelligence (AI) for endoscopic care by unveiling ColonPRO™, the latest generation software for the GI Genius™ intelligent endoscopy system developed by Cosmo IMD, along with a new strategic collaboration designed to enhance patient care.